The HtrA1 Promoter Polymorphism, Smoking, and Age-related Macular Degeneration in Multiple Case-control Samples

Ophthalmology

Volumn 115, Issue 11, 2008, Pages 1891-1898

  Tuo, Jingsheng ^a   Ross, Robert J ^a   Reed, George F ^a   Yan, Qing ^a   Wang, Jie Jin ^b   Bojanowski, Christine M ^a   Chew, Emily Y ^a   Feng, Xiao ^c   Olsen, Timothy W ^c   Ferris III, Frederick L ^a   Mitchell, Paul ^b   Chan, Chi Chao ^a  

^a NATIONAL EYE INSTITUTE   (United States)

^b WESTMEAD HOSPITAL   (Australia)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT FACTOR H; PROTEIN HTRA1; SERINE PROTEINASE; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; SINGLE NUCLEOTIDE POLYMORPHISM; SUBRETINAL NEOVASCULARIZATION;

AGED; CASE-CONTROL STUDIES; CHOLESTEROL; COMPLEMENT FACTOR H; FEMALE; GENOTYPE; HUMANS; IMMUNOENZYME TECHNIQUES; MACULAR DEGENERATION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK FACTORS; SERINE ENDOPEPTIDASES; SMOKING;

EID: 54949101967     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2008.05.021     Document Type: Article

References (65)

1. Klein R., Peto T., Bird A., and Vannewkirk M.R. The epidemiology of age-related macular degeneration. Am J Ophthalmol 137 (2004) 486-495
2. Tuo J., Bojanowski C.M., and Chan C.C. Genetic factors of age-related macular degeneration. Prog Retin Eye Res 23 (2004) 229-249
3. Haddad S., Chen C.A., Santangelo S.L., and Seddon J.M. The genetics of age-related macular degeneration: a review of progress to date. Surv Ophthalmol 51 (2006) 316-363
4. Mullins R.F. Genetic insights into the pathobiology of age-related macular degeneration. Int Ophthalmol Clin 47 (2007) 1-14
5. Ross R.J., Verma V., Rosenberg K.I., et al. Genetic markers and biomarkers for age-related macular degeneration. Expert Rev Ophthalmol 2 (2007) 443-457
6. Tan J.S., Mitchell P., Smith W., and Wang J.J. Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Ophthalmology 114 (2007) 1143-1150
7. Tuo J., Smith B., Bojanowski C.M., et al. The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age-related macular degeneration. FASEB J 18 (2004) 1297-1299
8. Edwards A.O., Ritter III R., Abel K.J., et al. Complement factor H polymorphism and age-related macular degeneration. Science 308 (2005) 421-424
9. Haines J.L., Hauser M.A., Schmidt S., et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 308 (2005) 419-421
10. Hageman G.S., Anderson D.H., Johnson L.V., et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A 102 (2005) 7227-7232
11. Zareparsi S., Buraczynska M., Branham K.E., et al. Toll-like receptor 4 variant D299G is associated with susceptibility to age-related macular degeneration. Hum Mol Genet 14 (2005) 1449-1455
12. Chan C.C., Tuo J., Bojanowski C.M., et al. Detection of CX3CR1 single nucleotide polymorphism and expression on archived eyes with age-related macular degeneration. Histol Histopathol 20 (2005) 857-863
13. Bojanowski C.M., Shen D., Chew E.Y., et al. An apolipoprotein E variant may protect against age-related macular degeneration through cytokine regulation. Environ Mol Mutagen 47 (2006) 594-602
14. Tuo J., Ning B., Bojanowski C.M., et al. Synergic effect of polymorphisms in ERCC6 5′ flanking region and complement factor H on age-related macular degeneration predisposition. Proc Natl Acad Sci U S A 103 (2006) 9256-9261
15. Postel E.A., Agarwal A., Caldwell J., et al. Complement factor H increases risk for atrophic age-related macular degeneration. Ophthalmology 113 (2006) 1504-1507
16. Seddon J.M., George S., Rosner B., and Klein M.L. CFH gene variant, Y402H, and smoking, body mass index, environmental associations with advanced age-related macular degeneration. Hum Hered 61 (2006) 157-165
17. Maller J., George S., Purcell S., et al. Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nat Genet 38 (2006) 1055-1059
18. Gold B., Merriam J.E., Zernant J., et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet 38 (2006) 458-462
19. Shastry B.S. Further support for the common variants in complement factor H (Y402H) and LOC387715 (A69S) genes as major risk factors for the exudative age-related macular degeneration. Ophthalmologica 220 (2006) 291-295
20. Conley Y.P., Jakobsdottir J., Mah T., et al. CFH, ELOVL4, PLEKHA1, and LOC387715 genes and susceptibility to age-related maculopathy: AREDS and CHS cohorts and meta-analyses. Hum Mol Genet 15 (2006) 3206-3218
21. Hyman L., Schachat A.P., He Q., Leske M.C., and Age-Related Macular Degeneration Risk Factors Study Group. Hypertension, cardiovascular disease, and age-related macular degeneration. Arch Ophthalmol 118 (2000) 351-358
22. Seddon J.M., Francis P.J., George S., et al. Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. JAMA 297 (2007) 1793-1800
23. Majewski J., Schultz D.W., Weleber R.G., et al. Age-related macular degeneration-a genome scan in extended families. Am J Hum Genet 73 (2003) 540-550
24. Seddon J.M., Santangelo S.L., Book K., et al. A genomewide scan for age-related macular degeneration provides evidence for linkage to several chromosomal regions. Am J Hum Genet 73 (2003) 780-790
25. Kenealy S.J., Schmidt S., Agarwal A., et al. Linkage analysis for age-related macular degeneration supports a gene on chromosome 10q26. Mol Vis 10 (2004) 57-61
26. Iyengar S.K., Song D., Klein B.E., et al. Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration. Am J Hum Genet 74 (2004) 20-39
27. Weeks D.E., Conley Y.P., Tsai H.J., et al. Age-related maculopathy: a genomewide scan with continued evidence of susceptibility loci within the 1q31, 10q26, and 17q25 regions. Am J Hum Genet 75 (2004) 174-189
28. Jakobsdottir J., Conley Y.P., Weeks D.E., et al. Susceptibility genes for age-related maculopathy on chromosome 10q26. Am J Hum Genet 77 (2005) 389-407
29. Ross R.J., Bojanowski C.M., Wang J.J., et al. The LOC387715 polymorphism and age-related macular degeneration: replication in three case-control samples. Invest Ophthalmol Vis Sci 48 (2007) 1128-1132
30. Shastry B.S. Assessment of the contribution of the LOC387715 gene polymorphism in a family with exudative age-related macular degeneration and heterozygous CFH variant (Y402H). J Hum Genet 52 (2007) 384-387
31. Dewan A., Liu M., Hartman S., et al. HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 314 (2006) 989-992
32. Yang Z., Camp N.J., Sun H., et al. A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science 314 (2006) 992-993
33. Oka C., Tsujimoto R., Kajikawa M., et al. HtrA1 serine protease inhibits signaling mediated by Tgfbeta family proteins. Development 131 (2004) 1041-1053
34. Tam P.O., Ng N.K., Liu D.T., et al. HTRA1 variants in exudative age-related macular degeneration and interactions with smoking and CFH. Invest Ophthalmol Vis Sci 49 (2008) 2357-2365
35. DeAngelis M.M., Ji F., Adams S., et al. Alleles in the HtrA serine peptidase 1 gene alter the risk of neovascular age-related macular degeneration. Ophthalmology 115 (2008) 1209-1215
36. Kanda A., Chen W., Othman M., et al. A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration. Proc Natl Acad Sci U S A 104 (2007) 16227-16232
37. Age-Related Eye Disease Study Research Group. The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1. Control Clin Trials 20 (1999) 573-600
38. Foran S., Wang J.J., and Mitchell P. Causes of visual impairment in two older population cross-sections: the Blue Mountains Eye Study. Ophthalmic Epidemiol 10 (2003) 215-225
39. Olsen T.W., and Feng X. The Minnesota Grading System of eye bank eyes for age-related macular degeneration. Invest Ophthalmol Vis Sci 45 (2004) 4484-4490
40. Klein R., Klein B.E., and Linton K.L. Prevalence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 99 (1992) 933-943
41. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 119 (2001) 1417-1436
42. Age-Related Eye Disease Study Research Group. Risk factors associated with age-related macular degeneration: a case-control study in the Age-Related Eye Disease study. Age-Related Eye Disease Study report number 3. Ophthalmology 107 (2000) 2224-2232
43. Attebo K., Mitchell P., and Smith W. Visual acuity and the causes of visual loss in Australia: the Blue Mountains Eye Study. Ophthalmology 103 (1996) 357-364
44. Mitchell P., Smith W., Attebo K., and Wang J.J. Prevalence of age-related maculopathy in Australia: the Blue Mountains Eye Study. Ophthalmology 102 (1995) 1450-1460
45. Bird A.C., Bressler N.M., Bressler S.B., et al., International ARM Epidemiological Study Group. An international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv Ophthalmol 39 (1995) 367-374
46. Smith W., Mitchell P., and Leeder S.R. Smoking and age-related maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol 114 (1996) 1518-1523
47. Age-Related Eye Disease Study Research Group. The effect of five-year zinc supplementation on serum zinc, serum cholesterol and hematocrit in persons randomly assigned to treatment group in the Age-Related Eye Disease Study: AREDS report no. 7. J Nutr 132 (2002) 697-702
48. Walter S.D. The distribution of Levin's measure of attributable risk. Biometrika 62 (1975) 371-374
49. Klein R.J., Zeiss C., Chew E.Y., et al. Complement factor H polymorphism in age-related macular degeneration. Science 308 (2005) 385-389
50. Chan C.C., Shen D., Zhou M., et al. Human HtrA1 in the archived eyes with age-related macular degeneration. Trans Am Ophthalmol Soc 105 (2007) 92-98. http://www.aosonline.org/xactions/2007/1545-6110_v105_p092.pdf Accessed April 19, 2008
51. Cameron D.J., Yang Z., Gibbs D., et al. HTRA1 variant confers similar risks to geographic atrophy and neovascular age-related macular degeneration. Cell Cycle 6 (2007) 1122-1125
52. Spencer K.L., Hauser M.A., Olson L.M., et al. Deletion of CFHR3 and CFHR1 genes in age-related macular degeneration. Hum Mol Genet 17 (2008) 971-977
53. Hughes A.E., Orr N., Esfandiary H., et al. A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat Genet 38 (2006) 1173-1177
54. Okamoto H., Umeda S., Obazawa M., et al. Complement factor H polymorphisms in Japanese population with age-related macular degeneration. Mol Vis 12 (2006) 156-158
55. Uka J., Tamura H., Kobayashi T., et al. No association of complement factor H gene polymorphism and age-related macular degeneration in the Japanese population. Retina 26 (2006) 985-987
56. Fuse N., Miyazawa A., Mengkegale M., et al. Polymorphisms in complement factor H and hemicentin-1 genes in a Japanese population with dry-type age-related macular degeneration. Am J Ophthalmol 142 (2006) 1074-1076
57. Chen L.J., Liu D.T., Tam P.O., et al. Association of complement factor H polymorphisms with exudative age-related macular degeneration. Mol Vis 12 (2006) 1536-1542
58. Mori K., Horie-Inoue K., Kohda M., et al. Association of the HTRA1 gene variant with age-related macular degeneration in the Japanese population. J Hum Genet 52 (2007) 636-641
59. Yoshida T., Dewan A., Zhang H., et al. HTRA1 promoter polymorphism predisposes Japanese to age-related macular degeneration. Mol Vis 13 (2007) 545-548
60. Ioannidis J.P., Ntzani E.E., Trikalinos T.A., and Contopoulos-Ioannidis D.G. Replication validity of genetic association studies. Nat Genet 29 (2001) 306-309
61. Lohmueller K.E., Pearce C.L., Pike M., et al. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 33 (2003) 177-182
62. Leveziel N., Zerbib J., Richard F., et al. Genotype-phenotype correlations for exudative age-related macular degeneration associated with homozygous HTRA1 and CFH genotypes. Invest Ophthalmol Vis Sci 49 (2008) 3090-3094
63. Gilicze A., Kohalmi B., Pocza P., et al. HtrA1 is a novel mast cell serine protease of mice and men. Mol Immunol 44 (2007) 2961-2968
64. De Luca A., De Falco M., De Luca L., et al. Pattern of expression of HtrA1 during mouse development. J Histochem Cytochem 52 (2004) 1609-1617
65. Chien J., Staub J., Hu S.I., et al. A candidate tumor suppressor HtrA1 is downregulated in ovarian cancer. Oncogene 23 (2004) 1636-1644